News

90 seconds with PhD student Bronwyn Smithies

An international research team has advanced our understanding of the genetic factors contributing to the risk of developing motor neurone disease (MND), a devastating disorder that kills two Australians each day.

Dr Nathan Palpant studies human heart development using stem cells, to generate beating cardiac muscle cells in a dish. For this work, he received a UQ Foundation Research Excellence Award in recognition of the contribution he has made to an international effort to fight cardiovascular disease, the leading cause of death globally. 

Queensland researchers have discovered a potential treatment for the severe inflammation caused by infectious mosquito-borne diseases responsible for several outbreaks worldwide in the past decade.

Researchers have built molecular switches that can control the immune response to many common allergens

Researchers have advanced their understanding of how a healthy embryo forms in its very earliest days, a discovery that could be used to improve IVF and preimplantation genetic diagnosis (PGD).

When Dr Jeffrey Mak, UQ IMB and Imaging CoE postdoctoral researcher in Prof David Fairlie’s lab was awarded one of only 25 prestigious places in the international SciFinder Future Leaders program, he had the opportunity of a lifetime to bolster his professional path with powerful new knowledge, skills and relationships.

A genetic analysis of a type of edible red seaweed has revealed how it has survived for over a billion years and thrives in harsh conditions, and how the health benefits of this important crop may be improved in the future.

An IMB researcher has received funding to create a simple, affordable biosensor for monitoring biological information in real time.

An international team of researchers has found a drug previously approved to treat breast cancer could also be used to shrink medulloblastoma, a common form of childhood brain tumour.

A research paper published in Nature journal overnight revealed that scientists had successfully edited the genomes of human embryos to prevent a mutation that causes hypertrophic cardiomyopathy, an inherited condition that causes sudden heart failure in young people.

IMB scientists have discovered a promising new approach to treat pain from tarantula venom.

IMB researchers are identifying pathways that contribute to pain, to help the one in five Australians who live with chronic pain.

Across Australia’s vast outback, parasitic worms are crippling sheep production. The little-known, blood-sucking Barber's Pole worm is one of the most dangerous, commonly killing infected sheep.

IMB's Dr Larisa Labzin has won the NHMRC Frank Fenner Award for having the top-ranked early career research fellowship in 2016.

Professor Peter Koopman speaks about his research into CRISPR and the possibilities it could offer to future generations, as well as those suffering from genetic conditions right now.

A discovery by University of Queensland researchers about the evolution of a tiny fish could have implications for sufferers of muscle diseases such as muscular dystrophy.

IMB PhD student Andrew White will network with Nobel Prize winners at the 67th Lindau Nobel Laureate Meeting later this month.

Professor Yang, a statistical genomics researcher, received the Senior Researcher Award at the Queensland ASMR Gala Dinner in Brisbane on 2 June during ASMR Medical Research Week.

UQ IMB spinout company, Protagonist Therapeutics Inc., recently announced that it has initiated a Phase 1 clinical study and entered into a $1 billion worldwide agreement with a global pharmaceutical company.